/wp-content/uploads/candel_logo.svg00cchan@candeltx.com/wp-content/uploads/candel_logo.svgcchan@candeltx.com2021-07-15 05:00:192021-07-16 09:59:51Candel Therapeutics Appoints Diem Nguyen, Ph.D., M.B.A., to its Board of Directors
/wp-content/uploads/candel_logo.svg00cchan@candeltx.com/wp-content/uploads/candel_logo.svgcchan@candeltx.com2021-06-04 05:00:012021-07-16 10:13:53Candel Therapeutics Announces Data from Phase 1 Trial of CAN-3110 in Recurrent High-Grade Glioma at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
